Vivien Wong
Direttore/Membro del Consiglio presso CYCLO THERAPEUTICS, INC.
Patrimonio netto: 11 375 $ in data 30/04/2024
Profilo
Vivien Wong is currently an Independent Director at Cyclo Therapeutics, Inc. since 2023 and a Director at Burke Neurological Institute since 2022.
Previously, Dr. Wong worked as the Vice President-Product Development at Progenics Pharmaceuticals, Inc. from 2007 to 2021 and as a Principal at Theritas Pharmaceutical Consultants from 2004 to 2007.
Dr. Wong completed an undergraduate degree at Mississippi University for Women and a doctorate degree at the University of Maryland School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CYCLO THERAPEUTICS INC
0.03% | 01/03/2024 | 8 818 ( 0.03% ) | 11 375 $ | 30/04/2024 |
Posizioni attive di Vivien Wong
| Società | Posizione | Inizio |
|---|---|---|
| CYCLO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 17/08/2023 |
| Burke Neurological Institute | Direttore/Membro del Consiglio | 01/01/2022 |
Precedenti posizioni note di Vivien Wong
| Società | Posizione | Fine |
|---|---|---|
| Theritas Pharmaceutical Consultants | Corporate Officer/Principal | 01/09/2007 |
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2021 |
Formazione di Vivien Wong
| Mississippi University for Women | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CYCLO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
| Theritas Pharmaceutical Consultants | |
| Burke Neurological Institute |
- Borsa valori
- Insiders
- Vivien Wong